ATE401864T1 - Orale flüssige citalopram enthaltende formulierungen - Google Patents

Orale flüssige citalopram enthaltende formulierungen

Info

Publication number
ATE401864T1
ATE401864T1 AT05017678T AT05017678T ATE401864T1 AT E401864 T1 ATE401864 T1 AT E401864T1 AT 05017678 T AT05017678 T AT 05017678T AT 05017678 T AT05017678 T AT 05017678T AT E401864 T1 ATE401864 T1 AT E401864T1
Authority
AT
Austria
Prior art keywords
oral liquid
formulations containing
liquid formulations
containing citalopram
citalopram
Prior art date
Application number
AT05017678T
Other languages
English (en)
Inventor
Sandra Tavazzi
Original Assignee
Errekappa Euroterapici S P A
Medi Service S R L
Pharmacare S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Errekappa Euroterapici S P A, Medi Service S R L, Pharmacare S R L filed Critical Errekappa Euroterapici S P A
Application granted granted Critical
Publication of ATE401864T1 publication Critical patent/ATE401864T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05017678T 2005-05-05 2005-08-12 Orale flüssige citalopram enthaltende formulierungen ATE401864T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000301A ITTO20050301A1 (it) 2005-05-05 2005-05-05 Formulazioni liquide orali contenenti citalopram

Publications (1)

Publication Number Publication Date
ATE401864T1 true ATE401864T1 (de) 2008-08-15

Family

ID=37085321

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05017678T ATE401864T1 (de) 2005-05-05 2005-08-12 Orale flüssige citalopram enthaltende formulierungen

Country Status (5)

Country Link
EP (1) EP1726298B1 (de)
AT (1) ATE401864T1 (de)
DE (1) DE602005008398D1 (de)
ES (1) ES2311187T3 (de)
IT (1) ITTO20050301A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102415992A (zh) * 2011-11-24 2012-04-18 福格森（武汉）生物科技有限公司 依他普仑口服液体制剂
ITMI20120105A1 (it) * 2012-01-30 2013-07-31 Carthesia S A S Soluzione acquosa di escitalopram ossalato e relativo utilizzo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
EP2260844A1 (de) * 2003-05-27 2010-12-15 Merz Pharma GmbH & Co. KGaA Kombination eines NMDA-Rezeptorantagonisten und eines selektiven Serotonin-Wiederaufnahmeinhibitoren zur Behandlung von Depression und Gemütserkrankungen

Also Published As

Publication number Publication date
ITTO20050301A1 (it) 2006-11-06
EP1726298B1 (de) 2008-07-23
EP1726298A3 (de) 2007-05-09
EP1726298A2 (de) 2006-11-29
DE602005008398D1 (de) 2008-09-04
ES2311187T3 (es) 2009-02-01

Similar Documents

Publication Publication Date Title
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
ITTO20000779A0 (it) Composizioni farmaceutiche.
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
ITTO20010005A0 (it) Formulazione farmaceutica.
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
PT1501534E (pt) Formulacoes farmaceuticas
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
DE60322720D1 (de) Feste formulierungen enthaltend eine indolinon verbindung
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
BRPI0620229A8 (pt) formulação
DK1624869T3 (da) Doseringsform indeholdende pantoprazol som aktiv bestanddel
DK1608344T3 (da) Orale cladribin-formuleringer
DK1648440T3 (da) Halvfaste formuleringer til den orale indgivelse af taxoider
NO20064808L (no) Orale matrixformuleringer med licarbazepin
ATE401864T1 (de) Orale flüssige citalopram enthaltende formulierungen
NO20040966L (no) Orale vaksiner.
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
NL1025908A1 (nl) Farmaceutische combinatie.
FR2890312B1 (fr) Procede d'obtention d'un principe actif repulpant, principe actif obtenu et compositions cosmetiques l'incluant
EP1556022A4 (de) WûSSRIGE PHARMAZEUTISCHE 2,6-DIISOPROPYLPHENOL-ZUSAMMENSETZUNGEN

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties